These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 9876610)

  • 1. Product development studies on the tablet formulation of ibuprofen to improve bioavailability.
    Ghosh LK; Ghosh NC; Chatterjee M; Gupta BK
    Drug Dev Ind Pharm; 1998 May; 24(5):473-7. PubMed ID: 9876610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution.
    Park YJ; Kwon R; Quan QZ; Oh DH; Kim JO; Hwang MR; Koo YB; Woo JS; Yong CS; Choi HG
    Arch Pharm Res; 2009 May; 32(5):767-72. PubMed ID: 19471892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of a extended release tablet containing dexibuprofen.
    Yi HG; Chi MH; Kim YI; Woo JS; Park ES
    Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
    Hu L; Yang J; Liu W; Li L
    Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations.
    Klueglich M; Ring A; Scheuerer S; Trommeshauser D; Schuijt C; Liepold B; Berndl G
    J Clin Pharmacol; 2005 Sep; 45(9):1055-61. PubMed ID: 16100300
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
    Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
    Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory and pharmacokinetics evaluation of PEGylated ibuprofen tablet formulation.
    Mumuni M; Kenechukwu FC; Chime SA; Ogbonna JD; Mora AT
    Drug Deliv; 2014 Jun; 21(4):315-9. PubMed ID: 24191762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
    Patel N; Madan P; Lin S
    Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel ibuprofen-loaded solid dispersion with enhanced bioavailability using cycloamylose.
    Baek HH; Kim DH; Kwon SY; Rho SJ; Kim DW; Choi HG; Kim YR; Yong CS
    Arch Pharm Res; 2012 Mar; 35(4):683-9. PubMed ID: 22553061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note.
    Gohel M; Parikh R; Brahmbhatt B; Shah A
    AAPS PharmSciTech; 2007 Feb; 8(1):13. PubMed ID: 17408213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique.
    Li DX; Oh YK; Lim SJ; Kim JO; Yang HJ; Sung JH; Yong CS; Choi HG
    Int J Pharm; 2008 May; 355(1-2):277-84. PubMed ID: 18243606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of guar gum biopolymer in the prescription of tablets with sodium ibuprofen--quality tests and pharmaceutical availability in vitro.
    Berner-Strzelczyk A; Kołodziejska J; Zgoda MM
    Polim Med; 2006; 36(4):3-11. PubMed ID: 17402228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility and dissolution rate of ibuprofen in ionic and non-ionic micellar systems.
    Kokot Z; Zmidzińska H
    Acta Pol Pharm; 2001; 58(2):117-20. PubMed ID: 11501788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of ibuprofen gel formulations using experimental design technique for enhanced transdermal penetration.
    Rhee YS; Chang SY; Park CW; Chi SC; Park ES
    Int J Pharm; 2008 Nov; 364(1):14-20. PubMed ID: 18755258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citric acid as a pH-regulating additive in granules and the tablet matrix in enteric-coated formulations for colon-specific drug delivery.
    Nykänen P; Sten T; Jürjenson H; Veski P; Marvola M
    Pharmazie; 2004 Apr; 59(4):268-73. PubMed ID: 15125570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability study of two oral formulations of ibuprofen.
    Corpetti G; Rosignoli MT; Dionisio P
    Arzneimittelforschung; 1998 Apr; 48(4):392-5. PubMed ID: 9608882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres.
    Adeyeye CM; Price JC
    J Microencapsul; 1997; 14(3):357-77. PubMed ID: 9147285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
    Pabari RM; Ramtoola Z
    Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.